Renaissance Technologies’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-219,100
| Closed | -$460K | – | 3557 |
|
|
2016
Q4 | $460K | Buy |
219,100
+33,300
| +18% | +$69.9K | ﹤0.01% | 2787 |
|
|
2016
Q3 | $491K | Buy |
185,800
+16,700
| +10% | +$44.1K | ﹤0.01% | 2819 |
|
|
2016
Q2 | $321K | Buy |
169,100
+22,700
| +16% | +$43.1K | ﹤0.01% | 2928 |
|
|
2016
Q1 | $430K | Buy |
146,400
+41,300
| +39% | +$121K | ﹤0.01% | 2882 |
|
|
2015
Q4 | $328K | Buy |
105,100
+46,900
| +81% | +$146K | ﹤0.01% | 2861 |
|
|
2015
Q3 | $184K | Buy |
58,200
+23,000
| +65% | +$72.7K | ﹤0.01% | 2914 |
|
|
2015
Q2 | $134K | Buy |
+35,200
| New | +$134K | ﹤0.01% | 3058 |
|
|
2015
Q1 | – | Sell |
-12,549
| Closed | -$80K | – | 3455 |
|
|
2014
Q4 | $80K | Sell |
12,549
-25,600
| -67% | -$163K | ﹤0.01% | 2829 |
|
|
2014
Q3 | $187K | Sell |
38,149
-25,600
| -40% | -$125K | ﹤0.01% | 2568 |
|
|
2014
Q2 | $487K | Buy |
63,749
+26,700
| +72% | +$204K | ﹤0.01% | 2336 |
|
|
2014
Q1 | $391K | Buy |
37,049
+23,100
| +166% | +$244K | ﹤0.01% | 2434 |
|
|
2013
Q4 | $181K | Buy |
+13,949
| New | +$181K | ﹤0.01% | 2645 |
|
|
2013
Q3 | – | Sell |
-9,182
| Closed | -$52K | – | 3041 |
|
|
2013
Q2 | $52K | Buy |
+9,182
| New | +$52K | ﹤0.01% | 2693 |
|